Diffregen Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Diffregen General Information

Description

Developer of therapeutics drugs designed to stop the progression of cancer and activate the healthy immune system. The company uses active ingredients that are based on Angiocidin, a protein that has been shown to activate monocytes and drive terminal differentiation of leukemia cells, enabling acute myeloid leukemia patients to get proper treatment against cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 440 Coldstream Drive
  • Berwyn, PA 19312
  • United States
+1 (610) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diffregen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 21-Feb-2018 Completed Startup
2. Grant 01-Jan-2013 00000 Completed Startup
1. Grant 01-Jan-2011 $100K Completed Startup
To view Diffregen’s complete valuation and funding history, request access »

Diffregen Executive Team (4)

Name Title Board Seat Contact Info
Deni Zodda Chief Executive Officer
George Tuszynski Ph.D Co-Founder
Charles Swindell Ph.D Chief Scientific Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Diffregen Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MassChallenge Accelerator/Incubator 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Science Center Accelerator/Incubator 000 0000 000000 0
To view Diffregen’s complete investors history, request access »

Diffregen FAQs

  • When was Diffregen founded?

    Diffregen was founded in 2011.

  • Who is the founder of Diffregen?

    George Tuszynski Ph.D and Daniel Hussey are the founders of Diffregen.

  • Who is the CEO of Diffregen?

    Deni Zodda is the CEO of Diffregen.

  • Where is Diffregen headquartered?

    Diffregen is headquartered in Berwyn, PA.

  • What industry is Diffregen in?

    Diffregen’s primary industry is Drug Discovery.

  • Is Diffregen a private or public company?

    Diffregen is a Private company.

  • What is Diffregen’s current revenue?

    The current revenue for Diffregen is 00000.

  • Who are Diffregen’s investors?

    MassChallenge, U.S. Department of Health and Human Services, and Science Center have invested in Diffregen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »